CRA Family Trust has officially submitted its annual compliance certificate for the financial year ending March 31, 2026. The filing, issued by a chartered accountant, confirms the trust’s adherence to all necessary operational and regulatory requirements associated with its holdings in Alembic Pharmaceuticals Limited. This disclosure provides transparency regarding the trust’s ongoing commitment to corporate governance standards for the fiscal period.
Annual Compliance Certification
CRA Family Trust has successfully concluded its annual compliance verification process for the financial year ended March 31, 2026. The process involved a rigorous review of the trust’s adherence to its established operational mandates. The trust has proactively engaged independent chartered accountants to certify that all specified provisions and internal guidelines were followed throughout the fiscal year.
Assurance of Operational Standards
The verification, conducted by D. K. Mehta & Co., serves as an official confirmation that the trust maintains high standards of transparency. The certificate, issued under the signature of CA Divyesh K. Mehta, validates that the entity remains in full compliance with its stated obligations as of April 2, 2026. This filing ensures that all required governance benchmarks have been met, reinforcing the trust’s accountability to stakeholders and the wider market.
Source: BSE
